Affimed to Present at the Cantor Global Healthcare Conference 2024
September 10 2024 - 6:30AM
Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a
clinical-stage immuno-oncology company committed to giving patients
back their innate ability to fight cancer, announced today that its
Chief Executive Officer, Shawn M. Leland, PharmD, RPh, will
participate in a fireside chat at the Cantor Global Healthcare
Conference 2024 on Tuesday, September 17, 2024 at 8:00 a.m. Eastern
Daylight Time / 14:00 Central European Time.
A live webcast of the presentation will be
accessible on Affimed’s website at
https://www.affimed.com/investors/webcasts-and-corporate-presentation/.
A replay of the call will be archived on Affimed’s website for 30
days after the call.
For more information on the conference or to
schedule a one-on-one meeting with Affimed’s management, please
contact your Cantor Fitzgerald representative or Alex Fudukidis via
email at a.fudukidis@affimed.com or phone at +1 (917) 436-8102.
About Affimed N.V.Affimed
(Nasdaq: AFMD) is a clinical-stage immuno-oncology company
committed to giving patients back their innate ability to fight
cancer by actualizing the untapped potential of the innate immune
system. The Company’s innate cell engagers (ICE®) enable a
tumor-targeted approach to recognize and kill a range of
hematologic and solid tumors. ICE® are generated on the Company’s
proprietary ROCK® platform which predictably generates customized
molecules that leverage the power of innate immune cells to destroy
tumor cells. A number of ICE® molecules are in clinical
development, being studied as mono- or combination therapy.
Headquartered in Mannheim, Germany, Affimed is led by an
experienced team of biotechnology and pharmaceutical leaders united
by a bold vision to stop cancer from ever derailing patients’
lives. For more about the Company’s people, pipeline and partners,
please visit: www.affimed.com.
Investor Relations ContactAlexander
FudukidisDirector, Head of Investor RelationsE-Mail:
a.fudukidis@affimed.comTel.: +1 (917) 436-8102
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Sep 2023 to Sep 2024